{
    "Trade/Device Name(s)": [
        "MicroScan MICroSTREP plus Panels with Linezolid",
        "MicroScan MICroSTREP plus Panels"
    ],
    "Submitter Information": "Siemens Healthcare Diagnostics, Inc.",
    "510(k) Number": "K111677",
    "Predicate Device Reference 510(k) Number(s)": [
        "K020556"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LRG",
        "JWY",
        "LTW",
        "JTZ"
    ],
    "Summary Letter Date": "August 4, 2011",
    "Summary Letter Received Date": "June 15, 2011",
    "Submission Date": "May 31, 2011",
    "Regulation Number(s)": [
        "21CFR866.1640"
    ],
    "Regulation Name(s)": [
        "Antimicrobial susceptibility test powder"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Linezolid"
    ],
    "Specimen Type(s)": [
        "Colonies grown on solid media"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "MicroScan WalkAway System"
    ],
    "Method(s)/Technology(ies)": [
        "Broth microdilution",
        "Manual visual read",
        "Automated read"
    ],
    "Methodologies": [
        "Broth dilution susceptibility testing"
    ],
    "Submission Type(s)": [
        "Panel"
    ],
    "Document Summary": "FDA 510(k) summary for Siemens MicroScan MICroSTREP plus Panels with Linezolid for antimicrobial susceptibility testing of streptococci.",
    "Indications for Use Summary": "Determines quantitative and/or qualitative antimicrobial agent susceptibility of aerobic streptococci, including Streptococcus pneumoniae, Streptococcus pyogenes, Streptococcus agalactiae, and viridans group streptococci, including multi-drug resistant strains, using added Linezolid.",
    "fda_folder": "Microbiology"
}